News & Events

Webcast

Obalon Therapeutics, Inc. at the Canaccord Genuity 39th Annual Growth Conference

Aug 8, 2019 at 9:00 AM EDT

Webcast Presentation

Date	Title	Remind me
Aug 8, 2019 at 9:00 AM EDT	Obalon Therapeutics, Inc. at the Canaccord Genuity 39th Annual Growth Conference Click here for webcast Location InterContinental Hotel, Boston, MA

IMPORTANT SAFETY INFORMATION
The Obalon Balloon System is intended for adults with a body mass index (BMI) of 30 to 40 kg/m² willing to follow a diet and exercise program. All Obalon balloons must be removed in 6 months. Patients with prior weight loss surgeries are not eligible. The most common side effects reported were mild abdominal pain and nausea which typically resolved within two weeks. You must take daily acid-blocking medicine prescribed by your doctor. For full Important Safety Information click onSafety Information and Patient Labeling

Date	Title
Jul 24, 2019 at 8:30 AM EDT	Obalon Second Quarter 2019 Financial Results Conference Call
Mar 19, 2019 at 2:30 PM PDT	Obalon Therapeutics, Inc. at the 31st Annual ROTH Conference
Feb 22, 2019 at 8:30 AM EST	Obalon Fourth Quarter 2018 Financial Results Conference Call
Jan 3, 2019 at 8:30 AM EST	Obalon Commercial Update Call Post FDA Approval of Obalon Navigation
Nov 15, 2018 at 1:30 PM EST	Obalon Therapeutics, Inc. at the Canaccord Genuity Medical Technologies & Diagnostics Forum
Nov 14, 2018 at 1:15 PM EST	Obalon Therapeutics, Inc. at the Stifel Healthcare Conference
Nov 2, 2018 at 8:30 AM EDT	Obalon Third Quarter 2018 Financial Results Conference Call
Sep 10, 2018 at 10:00 AM EDT	Obalon Therapeutics, Inc. Corporate Strategy Update Call
Aug 9, 2018 at 9:00 AM EDT	Obalon Therapeutics, Inc. at the Canaccord Genuity 38th Annual Growth Conference